Untreated Subclinical Hypothyroidism is Associated with Higher Mortality and Hepatic Decompensation in Patients with MASLD/MASH: A Multinational Analysis

Authors

Do Han Kim MD, Department of Medicine, Mount Sinai Morningside and West, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Donghyun Ko MD, Department of Internal Medicine, Bridgeport Hospital, Yale New Haven Health, Bridgeport, CT, USA.Follow
Jose A. Porres, Universidad Francisco Marroquin, Guatemala City, Guatemala.
Wilhelm S. Basegoda MD, University of South Alabama, Mobile, AL, USA
Cristina H. Makarian, Universidad Francisco Marroquín, Facultad de Medicina, Guatemala City, Guatemala
Luis M. Nieto MD, Division of Gastroenterology and Hepatology, Emory University, Atlanta, GA, USA.
Pedro Palacios Argueta MD, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA, USA
Paul T. Kroner MD, Department of Gastroenterology, Riverside Health System, Newport News, VA, USA.
Frank J. Lukens MD, Division of Gastroenterology and Hepatology, Mayo Clinic Florida, Jacksonville, FL, USA

Document Type

Conference Proceeding

Abstract

This study aims to explore whether subclinical hypothyroidism contributes to the progression of MASLD/MASH, reflected as an increased risk of liver-related outcomes.

Publication Date

5-2025

Recommended Citation

Kim, Do Han MD; Ko, Donghyun MD; Porres, Jose A.; Basegoda, Wilhelm S. MD; Makarian, Cristina H.; Nieto, Luis M. MD; Palacios Argueta, Pedro MD; Kroner, Paul T. MD; and Lukens, Frank J. MD, "Untreated Subclinical Hypothyroidism is Associated with Higher Mortality and Hepatic Decompensation in Patients with MASLD/MASH: A Multinational Analysis" (2025). Posters. 95.
https://scholar.bridgeporthospital.org/poster_presentations/95